Community/Retail

The deal is worth approximately $1.055 billion in cash, subject to customary adjustments.

Pharmacists can serve as an important resource for patients traveling abroad.

This announcement follows the FDA's decision to lift the partial clinical hold on the tanezumab development program. after a review of a robust body of nonclinical data characterizing the sympathetic nervous system response to tanezumab

Glyxambi is now available by prescription at pharmacies across the United States.

Tablets that incorporate mobile health (mHealth) technology may help health care professionals screen pregnant patients for depression.

Knowing what the experts think will happen in the future can help us better prepare for it.

In its 10th year, the Companion Vector-Borne Diseases (CVBD®) World Forum leads a global public health conversation on vector-borne diseases under the banner: "One Health: joining efforts for a healthier world".

The legislation addresses the shortcomings of the current MTM qualification system, but it has some shortcomings of its own.

This year's pharmacy residency matches have been released, stirring up emotions ranging from sheer satisfaction to dread and panic.

New Corporate Identity and Brand Reflect Company's Heritage and Commitment to Patients and Science

Timothy R. Wright joins Teva as Executive Vice President, Business Development, Strategy and Innovation

The meeting will offer timely CPE sessions that will involve presentations and discussions by some of pharmacy's most knowledgeable speakers.

Updated resource can help improve medication management for seniors.

Julie Johnson, PharmD, dean of the University of Florida's College of Pharmacy, has won the 2015 Distinguished Scientist Award from the Southeastern Universities Research Association.

A health-system pharmacist was recently let go after peeking at the health records of patients not in his care.

Vitamin D insufficiency may raise the odds of depressive symptoms in college-aged women.

Tighter hydrocodone regulations meant to reduce opioid abuse are hindering pain patients' access to the products.

The FDA's advisory committee supports the approval of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma in only adults.

As Homer's hero, Odysseus, once advised, "There is a time for many words, and there is a time for sleep."

This interview features Adma Metcalf, PharmD, of Hill Country Apothecary.

Patients with healthy diets may be more likely to use supplements.

The FDA is warning health care professionals and patients about OTC asthma products labeled as homeopathic remedies.

MOVANTIK is a first-in-class, once-daily, oral, peripherally-acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

The agreement creates possible new treatment options for cancer patients.

A pharmacy school team nabbed second place in the Mississippi Public Universities' Blueprint Mississippi Social Business Challenge.

Stories on drug manufacturers' patent-protection strategies suggest that the high costs of some drugs are receiving attention from other health care team members, as well as government officials.

The Virginia Commonwealth University School of Pharmacy dean's advice for graduating students is to think about what employers are looking for when they hire pharmacists.

Now in its sixth year, the annual program recognizes outstanding pharmacists, technicians, student pharmacists and industry advocates.

Seniors with dementia who take antipsychotics may face a higher risk of death than previously thought.